Compare ASH & MMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ASH | MMS |
|---|---|---|
| Founded | 1924 | 1975 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Chemicals | Business Services |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 3.2B |
| IPO Year | 2016 | 1997 |
| Metric | ASH | MMS |
|---|---|---|
| Price | $66.40 | $59.67 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $65.57 | N/A |
| AVG Volume (30 Days) | ★ 774.4K | 694.4K |
| Earning Date | 04-28-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.38% | 2.02% |
| EPS Growth | N/A | ★ 10.42 |
| EPS | 0.08 | ★ 3.50 |
| Revenue | $1,824,000,000.00 | ★ $2,392,236,000.00 |
| Revenue This Year | $2.58 | $0.44 |
| Revenue Next Year | $4.28 | $5.15 |
| P/E Ratio | $832.00 | ★ $16.40 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $46.30 | $52.73 |
| 52 Week High | $69.66 | $100.00 |
| Indicator | ASH | MMS |
|---|---|---|
| Relative Strength Index (RSI) | 52.79 | 58.44 |
| Support Level | $58.70 | $57.59 |
| Resistance Level | $67.71 | $60.78 |
| Average True Range (ATR) | 1.80 | 1.71 |
| MACD | -0.28 | 0.39 |
| Stochastic Oscillator | 52.05 | 84.77 |
Ashland Inc. is a specialty materials company serving markets including pharmaceuticals, personal care, food and beverages, coatings, construction, energy, and electronics. It operates through four segments: Life Sciences, Personal Care, Specialty Additives, and Intermediates. Life Sciences contributes the highest revenue, offering functional additives for pharmaceutical and nutrition applications. Personal Care provides ingredients for skin, hair, oral care, and household products, while Specialty Additives supplies performance-enhancing additives for coatings and. Intermediates produce BDO and related derivatives used in polymers, electronics, agriculture, and pharmaceutical applications. The company generates sales across North America, Europe, Asia Pacific, Latin America, and regions.
Maximus Inc designs, develops, and delivers programs enabling people to access vital government services. It translates health and human services public policy into operating models that achieve outcomes for governments at scale. The company covers a broad array of services, including the operation of large health insurance eligibility and enrollment programs; clinical services, including assessments, appeals, and independent medical reviews; and technology services. The company operates through the following segments: U.S. Federal Services, U.S. Services, and Outside the U.S. A majority of its revenue is derived from the U.S. Federal Services segment, which engages with various U.S. federal government agencies to deliver clinical services, maintenance services, and technology solutions.